Focusing on helping clinicians improve experiences for their patients, GE Healthcare is highlighting an innovative portfolio of molecular imaging technologies and agents at the 57th annual meeting of the Society of Nuclear Medicine (SNM), June 5-9, in Salt Lake City. Terri Bresenham, vice president for molecular imaging at GE Healthcare, provides an overview of what's being announced.
“Our vision for GE Healthcare's molecular imaging business is to apply innovation to improve the patient experience,” she says. “We have shortened traditional exam times and reduced dose without compromising a clinician's or researcher’s ability to understand a disease from the beginning.”
Note: Visit GE Healthcare's virtual event website — GE@SNM — where Bresenham will be hosting a live online chat at 8:00 a.m. Mountain Time on Tuesday, June 8.